Clonal evolution and therapeutic resistance in solid tumors

Frontiers in Pharmacology

Volumn 4 JAN, Issue , 2014, Pages

  Barrett, Michael T ^a,b   Lenkiewicz, Elizabeth ^a   Evers, Lisa ^a   Holley, Tara ^a   Ruiz, Christian ^c   Bubendorf, Lukas ^c   Sekulic, Aleksander ^b   Ramanathan, Ramesh K ^a,d   Von Hoff, Daniel D ^a,d  

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF BASEL   (Switzerland)

^d Virginia Piper Cancer Center   (United States)

Author keywords

ACGH; Clonal evolution; Flow cytometry; Next generation sequencing; Solid tumors

Indexed keywords

ANDROGEN; GENOMIC DNA; TUMOR MARKER;

ARTICLE; CANCER GENETICS; CELL POPULATION; CLONAL ANALYSIS; CLONAL EVOLUTION; CONTROLLED STUDY; DISEASE MARKER; DNA CONTENT; FEMALE; FLOW CYTOMETRY; GENE; GENE DELETION; GENOME; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MELANOMA; NUMB GENE; OVARY TUMOR; PANCREAS ADENOCARCINOMA; PLEURA EFFUSION; PLOIDY; PROSTATE CANCER; SOLID TUMOR; TUMOR RESISTANCE;

EID: 84875651352     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2013.00002     Document Type: Article

References (47)

1. Aguirre, A. J., Brennan, C., Bailey, G., Sinha, R., Feng, B., Leo, C., et al. (2004). High-resolution characterization of the pancreatic adenocarcinoma genome. Proc. Natl. Acad. Sci. U.S.A. 101, 9067-9072.
2. Barletta, A., Marzullo, F., Pellecchia, A., Montemurro, S., Labriola, A., Lomonaco, R., et al. (1998). DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues. Anticancer Res. 18, 1677-1682.
3. Barrett, M. T., Pritchard, D., Palanca-Wessels, C., Anderson, J., Reid, B. J., and Rabinovitch, P. S. (2003). Molecular phenotype of spontaneously arising 4N (G2-tetraploid) intermediates of neoplastic progression in Barrett's esophagus. Cancer Res. 63, 4211-4217.
4. Biankin, A. V., Waddell, N., Kassahn, K. S., Gingras, M. C., Muthuswamy, L. B., Johns, A. L., et al. (2012). Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399-405.
5. Bredel, M., Scholtens, D. M., Harsh, G. R., Bredel, C., Chandler, J. P., Renfrow, J. J., et al. (2009). A network model of a cooperative genetic landscape in brain tumors. JAMA 302, 261-275.
6. Cancer Genome Atlas Research, N. (2011). Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615.
7. Chen, S., Auletta, T., Dovirak, O., Hutter, C., Kuntz, K., El-Ftesi, S., et al. (2008). Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification. Cancer Biol. Ther. 7, 1793-1802.
8. Colaluca, I. N., Tosoni, D., Nuciforo, P., Senic-Matuglia, F., Galimberti, V., Viale, G., et al. (2008). NUMB controls p53 tumour suppressor activity. Nature 451, 76-80.
9. DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., et al. (2011). A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491-498.
10. Galipeau, P. C., Cowan, D. S., Sanchez, C. A., Barrett, M. T., Emond, M. J., Levine, D. S., et al. (1996). 17p (p53) Allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc. Natl. Acad. Sci. U.S.A. 93, 7081-7084.
11. Galipeau, P. C., Li, X., Blount, P. L., Maley, C. C., Sanchez, C. A., Odze, R. D., et al. (2007). NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. PLoS Med. 4:e67. doi:10.1371/journal.pmed.0040067
12. Gerlinger M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., et al. (2012). Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883-892.
13. Glogovac, J. K., Porter, P. L., Banker, D. E., and Rabinovitch, P. S. (1996). Cytokeratin labeling of breast cancer cells extracted from paraffin-embedded tissue for bivariate flow cytometric analysis. Cytometry 24, 260-267.
14. Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I. B., et al. (2012). Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat. Genet. 44, 694-698.
15. Holley, T., Lenkiewicz, E., Evers, L., Tembe, W., Ruiz, C., Gsponer, J. R., et al. (2012). Deep clonal profiling of formalin fixed paraffin embedded clinical samples. PLoS ONE 7:e50586. doi:10.1371/journal.pone.0050586
16. Ibrahim, S. F., and van den Engh, G. (2003). High-speed cell sorting: fundamentals and recent advances. Curr. Opin. Biotechnol. 14, 5-12.
17. Ibrahim, S. F., and van den Engh, G. (2008). Flow cytometry and cell sorting. Adv. Biochem. Eng. Biotechnol. 106, 19-39.
18. Jones, S., Zhang, X., Parsons, D. W., Lin, J. C., Leary, R. J., Angenendt, P., et al. (2008). Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801-1806.
19. Kimmelman, A. C., Hezel, A. F., Aguirre, A. J., Zheng, H., Paik, J. H., Ying, H., et al. (2008). Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Proc. Natl. Acad. Sci. U.S.A. 105, 19372-19377.
20. Koboldt, D. C., Chen, K., Wylie, T., Larson, D. E., McLellan, M. D., Mardis, E. R., et al. (2009). VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 25, 2283-2285.
21. Lai, L. A., Paulson, T. G., Li, X., Sanchez, C. A., Maley, C., Odze, R. D., et al. (2007). Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH. Genes Chromosomes Cancer 46, 532-542.
22. Leary, R. J., Lin, J. C., Cummins, J., Boca, S., Wood, L. D., Parsons, D. W., et al. (2008). Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc. Natl. Acad. Sci. U.S.A. 105, 16224-16229.
23. Li, H., and Durbin, R. (2009). Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760.
24. Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., et al. (2009). The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079.
25. Lipson, D., Aumann, Y., Ben-Dor, A., Linial, N., and Yakhini, Z. (2006). Efficient calculation of interval scores for DNA copy number data analysis. J. Comput. Biol. 13, 215-228.
26. Liu, S. V., Lenkiewicz, E., Evers, L., Holley, T., Kiefer, J., Ruiz, C., et al. (2012). Genomic analysis and selected molecular pathways in rare cancers. Phys. Biol. 9, 065004.
27. Liu, W., Laitinen, S., Khan, S., Vihinen, M., Kowalski, J., Yu, G., et al. (2009). Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat. Med. 15, 559-565.
28. Lofberg, R., Brostrom, O., Karlen, P., Ost, A., and Tribukait, B. (1992). DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia. Gastroenterology 102, 1149-1154.
29. Loo, L. W., Grove, D. I., Williams, E. M., Neal, C. L., Cousens, L. A., Schubert, E. L., et al. (2004). Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes. Cancer Res. 64, 8541-8549.
30. Maley, C. C., Galipeau, P. C., Finley, J. C., Wongsurawat, V. J., Li, X., Sanchez, C. A., et al. (2006). Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat. Genet. 38, 468-473.
31. McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., et al. (2010). The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297-1303.
32. Nik-Zainal, S., Alexandrov, L. B., Wedge, D. C., Van Loo, P., Greenman, C. D., Raine, K., et al. (2012). Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979-993.
33. Nowell, P. C. (1976). The clonal evolution of tumor cell populations. Science 194, 23-28.
34. Parsons, D. W., Jones, S., Zhang, X., Lin, J. C., Leary, R. J., Angenendt, P., et al. (2008). An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807-1812.
35. Prevo, L. J., Sanchez, C. A., Galipeau, P. C., and Reid, B. J. (1999). p53-Mutant clones and field effects in Barrett's esophagus. Cancer Res. 59, 4784-4787.
36. Rabinovitch, P. S. (1994). DNA content histogram and cell-cycle analysis. Methods Cell Biol. 41, 263-296.
37. Rabinovitch, P. S., Dziadon, S., Brentnall, T. A., Emond, M. J., Crispin, D. A., Haggitt, R. C., et al. (1999). Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res. 59, 5148-5153.
38. Rabinovitch, P. S., Longton, G., Blount, P. L., Levine, D. S., and Reid, B. J. (2001). Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables. Am. J. Gastroenterol. 96, 3071-3083.
39. Ruiz, C., Lenkiewicz, E., Evers, L., Holley, T., Robeson, A., Kiefer, J., et al. (2011). Advancing a clinically relevant perspective of the clonal nature of cancer. Proc. Natl. Acad. Sci. U.S.A. 108, 12054-12059.
40. Seymour, A. B., Hruban, R. H., Redston, M., Caldas, C., Powell, S. M., Kinzler, K. W., et al. (1994). Allelotype of pancreatic adenocarcinoma. Cancer Res. 54, 2761-2764.
41. Takanishi, D. M. Jr., Hart, J., Covarelli, P., Chappell, R., and Michelassi, F. (1996). Ploidy as a prognostic feature in colonic adenocarcinoma. Arch. Surg. 131, 587-592.
42. Tanaka, I., Masuda, R., Furuhata, Y., Inoue, M., Fujiwara, M., and Takemura, T. (1995). Flow cytometric analysis of the DNA content of adenocarcinoma of the lung, especially for patients with stage 1 disease with long term follow-up. Cancer 75, 2461-2465.
43. Veeriah, S., Taylor, B. S., Meng, S., Fang, F., Yilmaz, E., Vivanco, I., et al. (2010). Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat. Genet. 42, 77-82.
44. Weir, B. A., Woo, M. S., Getz, G., Perner, S., Ding, L., Beroukhim, R., et al. (2007). Characterizing the cancer genome in lung adenocarcinoma. Nature 450, 893-898.
45. Wong, D. J., Barrett, M. T., Stoger, R., Emond, M. J., and Reid, B. J. (1997). p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. Cancer Res. 57, 2619-2622.
46. Zhao, X., Li, C., Paez, J. G., Chin, K., Janne, P. A., Chen, T. H., et al. (2004). An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res. 64, 3060-3071.
47. Zong, C., Lu, S., Chapman, A. R., and Xie, X. S. (2012). Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science 338, 1622-1626.